Journal of nuclear medicine technology最新文献

筛选
英文 中文
The Effect of Monitored Walking on Extracardiac Intestinal Activity in Myocardial Perfusion Imaging. 监测步行对心肌灌注成像中心外膜肠活动的影响
IF 1
Journal of nuclear medicine technology Pub Date : 2024-09-17 DOI: 10.2967/jnmt.124.267917
Anja Strok, Maja Dolenc Novak, Barbara Guzic Salobir, Monika Stalc, Katja Zaletel
{"title":"The Effect of Monitored Walking on Extracardiac Intestinal Activity in Myocardial Perfusion Imaging.","authors":"Anja Strok, Maja Dolenc Novak, Barbara Guzic Salobir, Monika Stalc, Katja Zaletel","doi":"10.2967/jnmt.124.267917","DOIUrl":"https://doi.org/10.2967/jnmt.124.267917","url":null,"abstract":"<p><p>Various techniques have been used in attempts to reduce interfering gastrointestinal activity in myocardial perfusion imaging (MPI); however, these approaches have yielded inconsistent results. The goal of this study was to investigate the efficacy of monitored walking, a previously unexplored technique, in reducing subdiaphragmatic activity-related artifacts during pharmacologic stress <sup>99m</sup>Tc-tetrofosmin MPI with SPECT to improve the overall image quality. <b>Methods:</b> The study included patients who underwent MPI with pharmacologic stress. They were given a step counter immediately after the radiotracer injection and were randomized into a group A, with a request to walk at least 1,000 steps before imaging, and a group B, with no specific instructions about walking. The reconstructed SPECT images were assessed visually. Moderate and severe levels of subdiaphragmatic tracer activity were considered relevant for the interpretation of the scans. Additionally, myocardial and abdominal activity was semiquantitatively assessed on raw planar images, and the mean myocardium-to-abdomen count ratios were calculated. <b>Results:</b> We enrolled 199 patients (95 patients in group A and 104 patients in group B). Clinical characteristics did not differ significantly between the 2 groups. Patients in group A walked more steps than patients in group B (<i>P</i> < 0.001), but there were no differences in the proportion of accepted scans between the 2 groups (<i>P</i> = 0.41). Additionally, there were no differences in the proportion of relevant subdiaphragmatic activity between the groups (<i>P</i> = 0.91). The number of steps did not impact the acceptance rate (<i>P</i> = 0.29). <b>Conclusion:</b> A higher number of steps walked during the waiting period between pharmacologic stress and acquisition does not affect subdiaphragmatic activity-related artifacts or the proportion of accepted scans after pharmacologic stress. However, pedometer use and clear instructions motivate patients to walk while awaiting imaging. Larger studies are required to compare a higher-step-count group with a sedentary control group to assess the influence of walking on gastrointestinal artifacts in MPI.</p>","PeriodicalId":16548,"journal":{"name":"Journal of nuclear medicine technology","volume":null,"pages":null},"PeriodicalIF":1.0,"publicationDate":"2024-09-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142289486","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comment Regarding "Vapocoolant Analgesia for Breast Lymphoscintigraphy: A Prospective Clinical Trial". 关于 "乳腺淋巴管造影的蒸汽冷却剂镇痛:前瞻性临床试验 "发表的评论。
IF 1
Journal of nuclear medicine technology Pub Date : 2024-09-17 DOI: 10.2967/jnmt.124.267498
Andrew Ditto
{"title":"Comment Regarding \"Vapocoolant Analgesia for Breast Lymphoscintigraphy: A Prospective Clinical Trial\".","authors":"Andrew Ditto","doi":"10.2967/jnmt.124.267498","DOIUrl":"https://doi.org/10.2967/jnmt.124.267498","url":null,"abstract":"","PeriodicalId":16548,"journal":{"name":"Journal of nuclear medicine technology","volume":null,"pages":null},"PeriodicalIF":1.0,"publicationDate":"2024-09-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142289483","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Navigating a Transatlantic Career Shift: Guidance for U.S. Nuclear Medicine Technologists Looking to Relocate to the U.K. 跨大西洋职业转变的导航:为希望移居英国的美国核医学技术人员提供指导
IF 1
Journal of nuclear medicine technology Pub Date : 2024-09-17 DOI: 10.2967/jnmt.124.268651
Jessica Settle
{"title":"Navigating a Transatlantic Career Shift: Guidance for U.S. Nuclear Medicine Technologists Looking to Relocate to the U.K.","authors":"Jessica Settle","doi":"10.2967/jnmt.124.268651","DOIUrl":"https://doi.org/10.2967/jnmt.124.268651","url":null,"abstract":"","PeriodicalId":16548,"journal":{"name":"Journal of nuclear medicine technology","volume":null,"pages":null},"PeriodicalIF":1.0,"publicationDate":"2024-09-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142289484","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
So You Are a Clinical Instructor-Now What? 您是一名临床讲师--现在该怎么办?
IF 1
Journal of nuclear medicine technology Pub Date : 2024-09-17 DOI: 10.2967/jnmt.124.268054
Jennifer L Prekeges
{"title":"So You Are a Clinical Instructor-Now What?","authors":"Jennifer L Prekeges","doi":"10.2967/jnmt.124.268054","DOIUrl":"https://doi.org/10.2967/jnmt.124.268054","url":null,"abstract":"<p><p>Many nuclear medicine technologists find themselves in the role of clinical instructor, often without much in the way of educational background. This article provides a few recommendations on how to get started in this role. After distinguishing between the roles of affiliate education supervisor and clinical instructor, the article discusses 2 basic tools: the clinical course learning outcomes and the student handbook. Expectations for students are reviewed. An important aspect of clinical instruction is the attitude of the instructor. Clinical instructors can motivate students or demotivate them, with this choice having a significant impact on the student's development. Overall, the desire and determination to be pleasant and helpful to students make the greatest difference in their development into nuclear medicine technologists.</p>","PeriodicalId":16548,"journal":{"name":"Journal of nuclear medicine technology","volume":null,"pages":null},"PeriodicalIF":1.0,"publicationDate":"2024-09-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142289485","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
First-Strike Rapid Predictive Dosimetry and Dose Response for 177Lu-PSMA Therapy in Metastatic Castration-Resistant Prostate Cancer. 转移性钙化抗性前列腺癌 177Lu-PSMA 治疗的首次快速预测剂量测定和剂量反应。
IF 1
Journal of nuclear medicine technology Pub Date : 2024-09-05 DOI: 10.2967/jnmt.123.267067
Yung Hsiang Kao, Nadia Falzone, Michael Pearson, Dinesh Sivaratnam
{"title":"First-Strike Rapid Predictive Dosimetry and Dose Response for <sup>177</sup>Lu-PSMA Therapy in Metastatic Castration-Resistant Prostate Cancer.","authors":"Yung Hsiang Kao, Nadia Falzone, Michael Pearson, Dinesh Sivaratnam","doi":"10.2967/jnmt.123.267067","DOIUrl":"10.2967/jnmt.123.267067","url":null,"abstract":"<p><p>We devised and clinically validated a schema of rapid personalized predictive dosimetry for <sup>177</sup>Lu-PSMA-I&T in metastatic castration-resistant prostate cancer. It supersedes traditional empiric prescription by providing clinically meaningful predicted absorbed doses for first-strike optimization. <b>Methods:</b> Prostate-specific membrane antigen PET was conceptualized as a simulation study that captures the complex dosimetric interplay between tumor, marrow, and kidneys at a single time point. Radiation principles of fractionation, heterogeneity, normal-organ constraints (marrow, kidney), absorbed dose, and dose rate were introduced. We created a predictive calculator in the form of a free, open-source, and user-friendly spreadsheet that can be completed within minutes. Our schema achieves speed and accuracy by sampling tissue radioconcentrations (kBq/cm<sup>3</sup>) to be analyzed in conjunction with clinical input from the user that reflect dosimetric preconditions. The marrow-absorbed dose constraint was 0.217 Gy (dose rate, ≤0.0147 Gy/h) per fraction with an interfraction interval of at least 6 wk. <b>Results:</b> Our first 10 patients were analyzed. The first-strike mean tumor-absorbed dose threshold for any prostate-specific antigen (PSA) response was more than 10 Gy (dose rate, >0.1 Gy/h). The metastasis with the lowest first-strike tumor-absorbed dose correlated the best with the percentage decrease of PSA; its threshold to achieve hypothetical zero PSA was 20 Gy or more. Each patient's PSA doubling time can be used to personalize their unique absorbed dose-response threshold. The predicted mean first-strike prescription constrained by marrow-absorbed dose rate per fraction was 11.0 ± 4.0 GBq. Highly favorable conditions (tumor sink effect) were dosimetrically expressed as the combination of tumor-to-normal-organ ratios of more than 150 for marrow and more than 4 for kidney. Our schema obviates the traditional role of the SUV as a predictive parameter. <b>Conclusion:</b> Our rapid schema is feasible to implement in any busy real-world theranostics unit and exceeds today's best practice standards. Our dosimetric thresholds and predictive parameters can radiobiologically rationalize each patient's first-strike prescription down to a single becquerel. Favorable tumor-to-normal-organ ratios can be prospectively exploited by predictive dosimetry to optimize the first-strike prescription. The scientific framework of our schema may be applied to other systemic radionuclide therapies.</p>","PeriodicalId":16548,"journal":{"name":"Journal of nuclear medicine technology","volume":null,"pages":null},"PeriodicalIF":1.0,"publicationDate":"2024-09-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141432148","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Multiradionuclide Automatic Dispensing System for Syringes of Radiopharmaceuticals: The Effect on Operator Hand Dose. 用于放射性药物注射器的多放射性核素自动分配系统:对操作员手部剂量的影响
IF 1
Journal of nuclear medicine technology Pub Date : 2024-09-05 DOI: 10.2967/jnmt.124.267449
Else A Aalbersberg, Tammie T Cao, Chelvi Mylvaganan-Young, Desiree Verwoerd, Kirsten Peen, Mariska Sonneborn-Bols, Jeroen J M A Hendrikx
{"title":"A Multiradionuclide Automatic Dispensing System for Syringes of Radiopharmaceuticals: The Effect on Operator Hand Dose.","authors":"Else A Aalbersberg, Tammie T Cao, Chelvi Mylvaganan-Young, Desiree Verwoerd, Kirsten Peen, Mariska Sonneborn-Bols, Jeroen J M A Hendrikx","doi":"10.2967/jnmt.124.267449","DOIUrl":"10.2967/jnmt.124.267449","url":null,"abstract":"<p><p>The radiation exposure of the hands of nuclear medicine laboratory technicians is largely due to the dispensing of radiopharmaceuticals into syringes. To reduce this exposure, a multiradionuclide automatic dispensing system (ADS) for syringes of radiopharmaceuticals was introduced. The aim of this study was to determine the effect of this ADS on hand dose compared with manual dispensing. <b>Methods:</b> The total hand dose per month for all personnel (12 technicians) was measured with ring dosimeters at the base of the index finger for 13 mo: 7 mo with manual syringe dispensing (radiopharmaceuticals containing <sup>99m</sup>Tc,<sup>18</sup>F, <sup>177</sup>Lu, <sup>68</sup>Ga, <sup>90</sup>Y, and <sup>223</sup>Ra) and 6 mo with ADS (automatic: radiopharmaceuticals containing <sup>18</sup>F and <sup>177</sup>Lu; manual: radiopharmaceuticals containing <sup>99m</sup>Tc, <sup>68</sup>Ga, <sup>90</sup>Y, and <sup>223</sup>Ra). <b>Results:</b> The mean total hand dose per month was reduced from 52.8 ± 10.2 mSv with manual dispensing to 21.9 ± 2.7 mSv with ADS (<i>P</i> < 0.001), which is an absolute decrease of 59%. Meanwhile, the total handled activity increased from 369 to 505 GBq (<i>P</i> < 0.001). <sup>18</sup>F-containing radiopharmaceuticals were the most commonly dispensed, at 182 GBq per month. The increase in total handled activity was largely due to an increase in <sup>177</sup>Lu (from 25 to 123 GBq), partially because of the introduction of [<sup>177</sup>Lu]Lu-PSMA-I&T. When correcting for this increase in handled activity, the hand dose was reduced by 69%. <b>Conclusion:</b> The introduction of a multiradionuclide syringe ADS decreased the hand dose to personnel by 69% when corrected for the increase in handled activity. Expanding the number of radiopharmaceuticals being dispensed by the system could potentially further decrease personnel hand dose.</p>","PeriodicalId":16548,"journal":{"name":"Journal of nuclear medicine technology","volume":null,"pages":null},"PeriodicalIF":1.0,"publicationDate":"2024-09-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141432145","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Image Quality of Cardiac Silicon Photomultiplier PET/CT Using an Infant Phantom of Extremely Low Birth Weight. 使用极低出生体重婴儿模型的心脏硅光电倍增管 PET/CT 图像质量。
IF 1
Journal of nuclear medicine technology Pub Date : 2024-09-05 DOI: 10.2967/jnmt.124.267826
Kazuki Fukuchi, Takayuki Shibutani, Yusuke Terakawa, Yoshifumi Nouno, Emi Tateishi, Masahisa Onoguchi, Fukuda Tetsuya
{"title":"Image Quality of Cardiac Silicon Photomultiplier PET/CT Using an Infant Phantom of Extremely Low Birth Weight.","authors":"Kazuki Fukuchi, Takayuki Shibutani, Yusuke Terakawa, Yoshifumi Nouno, Emi Tateishi, Masahisa Onoguchi, Fukuda Tetsuya","doi":"10.2967/jnmt.124.267826","DOIUrl":"10.2967/jnmt.124.267826","url":null,"abstract":"<p><p>The lack of pediatrics-specific equipment for nuclear medicine imaging has resulted in insufficient diagnostic information for newborns, especially low-birth-weight infants. Although PET offers high spatial resolution and low radiation exposure, its use in newborns is limited. This study investigated the feasibility of cardiac PET imaging using the latest silicon photomultiplier (SiPM) PET technology in infants of extremely low birth weight (ELBW) using a phantom model. <b>Methods:</b> The study used a phantom model representing a 500-g ELBW infant with brain, cardiac, liver, and lung tissues. The cardiac tissue included a 3-mm-thick defect mimicking myocardial infarction. Organ tracer concentrations were calculated assuming <sup>18</sup>F-FDG myocardial viability scans and <sup>18</sup>F-flurpiridaz myocardial perfusion scans and were added to the phantom organs. Imaging was performed using an SiPM PET/CT scanner with a 5-min acquisition. The data acquired in list mode were reconstructed using 3-dimensional ordered-subsets expectation maximization with varying iterations. Image evaluation was based on the depiction of the myocardial defect compared with normal myocardial accumulation. <b>Results:</b> Increasing the number of iterations improved the contrast of the myocardial defect for both tracers, with <sup>18</sup>F-flurpiridaz showing higher contrast than <sup>18</sup>F-FDG. However, even at 50 iterations, both tracers overestimated the defect accumulation. A bull's-eye image can display the flow metabolism mismatch using images from both tracers. <b>Conclusion:</b> SiPM PET enabled cardiac PET imaging in a 500-g ELBW phantom with a 1-g heart. However, there were limitations in adequately depicting these defects. Considering the image quality and defect contrast,<sup>18</sup>F-flurpiridaz appears more desirable than <sup>18</sup>F-FDG if only one of the two can be used.</p>","PeriodicalId":16548,"journal":{"name":"Journal of nuclear medicine technology","volume":null,"pages":null},"PeriodicalIF":1.0,"publicationDate":"2024-09-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141432149","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison of Measurement and Prognostic Power of SUV Between High-Definition and Standard PET Imaging in Non-Small Cell Lung Cancer Patients. 非小细胞肺癌患者高清和标准 PET 成像的 SUV 测量和预后能力比较
IF 1
Journal of nuclear medicine technology Pub Date : 2024-09-05 DOI: 10.2967/jnmt.124.267684
Yonglin Pu, Bill C Penney, Jingmian Zhang, Kevin Little, Cassie A Simon, Nicholas Feinberg, Michael Hanzhe Zhang, Gloria Hwang, Daniel Eric Appelbaum
{"title":"Comparison of Measurement and Prognostic Power of SUV Between High-Definition and Standard PET Imaging in Non-Small Cell Lung Cancer Patients.","authors":"Yonglin Pu, Bill C Penney, Jingmian Zhang, Kevin Little, Cassie A Simon, Nicholas Feinberg, Michael Hanzhe Zhang, Gloria Hwang, Daniel Eric Appelbaum","doi":"10.2967/jnmt.124.267684","DOIUrl":"10.2967/jnmt.124.267684","url":null,"abstract":"<p><p>This study aimed to evaluate the measurement and prognostic ability of the SUV<sub>max</sub> of whole-body tumors (SUV<sub>maxwb</sub>) in non-small cell lung cancer (NSCLC) patients, comparing high-definition (HD) PET imaging with standard-definition (SD) PET imaging. <b>Methods:</b> The study included 242 consecutive NSCLC patients who underwent baseline <sup>18</sup>F-FDG PET/CT from April 2018 to January 2021. Two imaging techniques were used: HD PET (using ordered-subsets expectation maximization with point-spread function modeling and time-of-flight techniques and smaller voxels) and SD PET (with ordered-subsets expectation maximization and time-of-flight techniques). SUV<sub>maxwb</sub> was determined by measuring all the tumor lesions in the whole body, and tumor-to-background ratio (TBR) was calculated using the background SUV<sub>mean</sub> of various body parts. <b>Results:</b> The patient cohort had an average age of 68.3 y, with 59.1% being female. During a median follow-up of 29.6 mo, 83 deaths occurred. SUV<sub>maxwb</sub> was significantly higher in HD PET than SD PET, with respective medians of 17.4 and 11.8. The TBR of 1,125 tumoral lesions was also higher in HD PET. Univariate Cox regression analysis showed that SUV<sub>maxwb</sub> from both HD and SD PET were significantly associated with overall survival. However, after adjusting for TNM (tumor, node, metastasis) stage, only SUV<sub>maxwb</sub> from SD PET remained significantly associated with survival. <b>Conclusion:</b> HD PET imaging in NSCLC patients yields higher SUV<sub>maxwb</sub> and TBR, enhancing tumor visibility. Despite this, its prognostic value is less significant than SD PET after adjusting clinical TNM stage. Thus, consideration should be given to using HD PET reconstruction to increase tumor visibility, and SD PET is recommended for NSCLC patient prognostication and therapeutic evaluation, as well as for the classification of lung nodules.</p>","PeriodicalId":16548,"journal":{"name":"Journal of nuclear medicine technology","volume":null,"pages":null},"PeriodicalIF":1.0,"publicationDate":"2024-09-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141633672","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
90Y SIR-Spheres Activity Measurement with New SIROS D-Vial Delivery Kit. 使用新型 SIROS D 瓶输送套件进行 90Y SIR-Spheres 活性测量。
IF 1
Journal of nuclear medicine technology Pub Date : 2024-09-05 DOI: 10.2967/jnmt.124.267413
Benjamin P Lopez, S Cheenu Kappadath
{"title":"<sup>90</sup>Y SIR-Spheres Activity Measurement with New SIROS D-Vial Delivery Kit.","authors":"Benjamin P Lopez, S Cheenu Kappadath","doi":"10.2967/jnmt.124.267413","DOIUrl":"10.2967/jnmt.124.267413","url":null,"abstract":"<p><p>A new <sup>90</sup>Y SIR-Spheres delivery kit (SIROS D-vial and shield) has been introduced with a different physical form from the legacy V-Vial kit. Here, we establish the dose calibrator settings and exposure-rate-to-activity conversion factor to assay <sup>90</sup>Y SIR-Spheres activity in the new SIROS kit. <b>Methods:</b> Eight D-vials with initial <sup>90</sup>Y activities from 1.2 to 6.6 GBq within acrylic shields were assayed with dose calibrators and exposure-rate meters until activities decayed to approximately 0.1 GBq. The dose calibrator settings resulting in the lowest median activity errors and the best-fit slope of exposure rate versus activity were identified. <b>Results:</b> SIROS D-vial <sup>90</sup>Y activity can be accurately and reliably estimated directly using setting 51 × 10 on both the CRC-15R and the CRC-55tR dose calibrators (errors within ±0.5%) and indirectly with an exposure-rate reading at 30 cm using conversion factor 0.664 ± 0.003 GBq/(mR/h) (<i>R</i> <sup>2</sup> = 0.985). <b>Conclusion:</b> Dose calibrator settings and exposure-rate-to-activity conversion factor for <sup>90</sup>Y activity assays with new SIROS kit should be updated from legacy V-Vial parameters to avoid an approximately 10% underestimation.</p>","PeriodicalId":16548,"journal":{"name":"Journal of nuclear medicine technology","volume":null,"pages":null},"PeriodicalIF":1.0,"publicationDate":"2024-09-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141633671","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Can a Carbonated Lemon Drink Reduce Extracardiac Activity in Myocardial Perfusion Imaging? 碳酸柠檬饮料能减少心肌灌注成像中的心外活动吗?
IF 1
Journal of nuclear medicine technology Pub Date : 2024-09-05 DOI: 10.2967/jnmt.124.267965
Nora Al-Somali, Hossam El-Zeftawy, Salman Al-Qurashi, Nabeel Mishah, Jose Norwin Catipay, Leen Albalbeesi, Yasser Al-Eatany, Narjes Al-Alahmadii, Ali Alghamdi, Ahmed A Osman, Nadia Batawil
{"title":"Can a Carbonated Lemon Drink Reduce Extracardiac Activity in Myocardial Perfusion Imaging?","authors":"Nora Al-Somali, Hossam El-Zeftawy, Salman Al-Qurashi, Nabeel Mishah, Jose Norwin Catipay, Leen Albalbeesi, Yasser Al-Eatany, Narjes Al-Alahmadii, Ali Alghamdi, Ahmed A Osman, Nadia Batawil","doi":"10.2967/jnmt.124.267965","DOIUrl":"10.2967/jnmt.124.267965","url":null,"abstract":"<p><p>Myocardial perfusion imaging (MPI) provides physiologic and functional information about the heart muscle and its blood flow. Extracardiac radioactivity can interfere with visualization of the inferior wall of the myocardium, leading to poor-quality images, difficulties in interpretation, and delays in routine practice. This study aimed to identify the efficiency of having the patient consume a carbonated lemon drink to minimize the extracardiac radioactivity of <sup>99m</sup>Tc-sestamibi in comparison to <sup>99m</sup>Tc-tetrofosmin during MPI. <b>Methods:</b> This was a retrospective study that recruited 158 patients with known or suspected coronary artery disease referred to undergo <sup>99m</sup>Tc-sestamibi or <sup>99m</sup>Tc-tetrofosmin rest/stress single-day MPI. The patients were divided into 2 groups of mixed sexes and different ages. The first group comprised 78 patients injected with <sup>99m</sup>Tc-sestamibi, and the second group comprised 80 patients injected with <sup>99m</sup>Tc-tetrofosmin. For both groups, the patients drank 30 mL of fresh lemon juice diluted with 150 mL of soda water, and then we gave the patients about 100 mL of straight soda water, before imaging for both the rest and the stress phases. <b>Results:</b> Generally, in both groups, the <sup>99m</sup>Tc-tetrofosmin produced a good-quality image in comparison with the <sup>99m</sup>Tc-sestamibi. The mean rank of the total score for <sup>99m</sup>Tc-tetrofosmin (62.75) was less than that for <sup>99m</sup>Tc-sestamibi (96.68), and this difference was highly statistically significant (<i>P</i> = 0.000). There were statistically significant differences in the ratios and mean ranks for both groups in favor of <sup>99m</sup>Tc-tetrofosmin in patients having coronary artery disease. <b>Conclusion:</b> The use of a carbonated lemon drink minimizes extracardiac activity from both <sup>99m</sup>Tc-labeled MPI radiopharmaceuticals. This finding was more statistically significant for <sup>99m</sup>Tc-tetrofosmin MPI, providing better image quality and earlier imaging in both the rest and the stress phases because of faster hepatobiliary clearance.</p>","PeriodicalId":16548,"journal":{"name":"Journal of nuclear medicine technology","volume":null,"pages":null},"PeriodicalIF":1.0,"publicationDate":"2024-09-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141975923","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信